GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons Month 6 End of Study CENTRAL LABORATORY BLOOD NCT00079911

Study administration
Descrizione

Study administration

Subject Identifier
Descrizione

Subject Identifier

Tipo di dati

integer

Alias
UMLS CUI [1]
C2348585
Visit Date
Descrizione

Visit Date

Tipo di dati

date

Unità di misura
  • DD/MMM/YY
Alias
UMLS CUI [1]
C1320303
DD/MMM/YY
CENTRAL LABORATORY BLOOD
Descrizione

CENTRAL LABORATORY BLOOD

Date sample taken
Descrizione

Date sample taken

Tipo di dati

date

Alias
UMLS CUI [1]
C1302413
PREGNANCY TEST PROMPT
Descrizione

PREGNANCY TEST PROMPT

HIV RNA PROMPT
Descrizione

HIV RNA PROMPT

HIV-ASSOCIATED CONDITIONS
Descrizione

HIV-ASSOCIATED CONDITIONS

CONCOMITANT MEDICATIONS
Descrizione

CONCOMITANT MEDICATIONS

ADVERSE EVENTS
Descrizione

ADVERSE EVENTS

Similar models

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons Month 6 End of Study CENTRAL LABORATORY BLOOD NCT00079911

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Study administration
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Item Group
CENTRAL LABORATORY BLOOD
Date sample taken
Item
Date sample taken
date
C1302413 (UMLS CUI [1])
Item Group
PREGNANCY TEST PROMPT
Item Group
HIV RNA PROMPT
Item Group
HIV-ASSOCIATED CONDITIONS
Item Group
CONCOMITANT MEDICATIONS
Item Group
ADVERSE EVENTS